Company Filing History:
Years Active: 2004-2017
Title: Jose Teixeira: Innovator in Cancer Research
Introduction
Jose Teixeira is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. He holds 3 patents that focus on innovative methods and treatments for ovarian cancer. His work has the potential to greatly impact the field of oncology and improve patient outcomes.
Latest Patents
One of his latest patents is titled "Ovarian cancer stem cells and methods of isolation and uses thereof." This invention relates to methods, assays, compositions, and kits that focus on a specific subpopulation of ovarian cancer stem cells. These cells are selected or enriched by chemotherapeutic agents and inhibited by Mullerian Inhibiting Substance (MIS) and its mimetics. The invention provides methods to screen subjects with ovarian cancer to identify the presence of CD44+/CD24+/EpCam+/ECad− ovarian cancer stem cells.
Another notable patent is "Pyrazoloanthrone and derivatives thereof for the treatment of cancers expressing MISRII." This patent describes pyrazoloanthrones or their functional derivatives that activate MIS receptor-mediated effects in cells. The methods outlined in this patent aim to prevent and treat cancers that express MIS receptor type II (MISRII) by administering these compounds. Additionally, it includes methods to lower plasma androgen levels and decrease the effective dose of chemotherapeutic agents when combined with pyrazoloanthrones.
Career Highlights
Jose Teixeira is affiliated with The General Hospital Corporation, where he continues to advance his research in cancer treatment. His innovative approaches have garnered attention in the scientific community and have the potential to lead to new therapeutic options for patients.
Collaborations
Throughout his career, Teixeira has collaborated with notable colleagues, including Patricia K Donahoe and Eric Fynn-Thompson. These collaborations have enriched his research and contributed to the development of his patents.
Conclusion
Jose Teixeira's work in cancer research exemplifies the importance of innovation in medicine. His patents not only highlight his expertise but also pave the way for future advancements in the treatment of ovarian cancer.